- Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with metastatic or recurrent melanoma
This study is looking at a new treatment called ATL001 for advanced melanoma, a serious skin cancer. It aims to see how safe the treatment is and if it helps by checking for side effects and changes in tumour size.
For: Metastatic or recurrent melanomaSpain - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with advanced non-small cell lung cancer
This study is looking at a new treatment for advanced lung cancer. It combines a special cell therapy (ATL001) with existing treatments like KEYTRUDA. The main goal is to check how safe these treatments are and if they help shrink tumours. It's for adults with non-small cell lung cancer.
For: Non-small cell lung cancerSpain · Germany · France